Peptide dimer structure in an Aβ(1–42) fibril visualized with cryo-EM

Significance β-Amyloid (Aβ) fibrils are formed from Aβ peptide and are a hallmark feature of Alzheimer’s disease (AD). Despite their involvement in AD, much remains unclear about the formation of these aggregates and their structures at the molecular level. We have obtained a 3D image of a fibril formed from the Aβ(1–42) peptide isoform using electron cryomicroscopy and built a partial atomic model based on these data. We show that the core of the fibril is formed by two peptide C termini, explaining why aggregation inhibitors are most potent when targeting the C terminus. Our model explains how addition of C-terminal amino acids may stabilize peptide interaction and how fibril stability is affected by mutations leading to familial AD. Alzheimer’s disease (AD) is a fatal neurodegenerative disorder in humans and the main cause of dementia in aging societies. The disease is characterized by the aberrant formation of β-amyloid (Aβ) peptide oligomers and fibrils. These structures may damage the brain and give rise to cerebral amyloid angiopathy, neuronal dysfunction, and cellular toxicity. Although the connection between AD and Aβ fibrillation is extensively documented, much is still unknown about the formation of these Aβ aggregates and their structures at the molecular level. Here, we combined electron cryomicroscopy, 3D reconstruction, and integrative structural modeling methods to determine the molecular architecture of a fibril formed by Aβ(1–42), a particularly pathogenic variant of Aβ peptide. Our model reveals that the individual layers of the Aβ fibril are formed by peptide dimers with face-to-face packing. The two peptides forming the dimer possess identical tilde-shaped conformations and interact with each other by packing of their hydrophobic C-terminal β-strands. The peptide C termini are located close to the main fibril axis, where they produce a hydrophobic core and are surrounded by the structurally more flexible and charged segments of the peptide N termini. The observed molecular architecture is compatible with the general chemical properties of Aβ peptide and provides a structural basis for various biological observations that illuminate the molecular underpinnings of AD. Moreover, the structure provides direct evidence for a steric zipper within a fibril formed by full-length Aβ peptide.

[1]  S. Linse,et al.  The Aβ40 and Aβ42 peptides self-assemble into separate homomolecular fibrils in binary mixtures but cross-react during primary nucleation† †Electronic supplementary information (ESI) available. See DOI: 10.1039/c4sc02517b Click here for additional data file. , 2015, Chemical science.

[2]  R. Glockshuber,et al.  Atomic-Resolution Three-Dimensional Structure of Amyloid β Fibrils Bearing the Osaka Mutation , 2014, Angewandte Chemie.

[3]  Bradley T. Hyman,et al.  The Intersection of Amyloid Beta and Tau at Synapses in Alzheimer’s Disease , 2014, Neuron.

[4]  N. Grigorieff,et al.  Frealix: model-based refinement of helical filament structures from electron micrographs. , 2014, Journal of structural biology.

[5]  Michele Vendruscolo,et al.  Atomic structure and hierarchical assembly of a cross-β amyloid fibril , 2013, Proceedings of the National Academy of Sciences.

[6]  N. Grigorieff Direct detection pays off for electron cryo-microscopy , 2013, eLife.

[7]  D. Teplow,et al.  C-terminal turn stability determines assembly differences between Aβ40 and Aβ42. , 2013, Journal of molecular biology.

[8]  T. Härd,et al.  Inhibition of amyloid formation. , 2012, Journal of molecular biology.

[9]  U. Fink,et al.  An asymmetric dimer as the basic subunit in Alzheimer's disease amyloid β fibrils. , 2012, Angewandte Chemie.

[10]  P. Tessier,et al.  Structure-based design of conformation- and sequence-specific antibodies against amyloid β , 2011, Proceedings of the National Academy of Sciences.

[11]  Nikolaus Grigorieff,et al.  Recent progress in understanding Alzheimer's β-amyloid structures. , 2011, Trends in biochemical sciences.

[12]  R. Tycko Solid-state NMR studies of amyloid fibril structure. , 2011, Annual review of physical chemistry.

[13]  David Eisenberg,et al.  Identifying the amylome, proteins capable of forming amyloid-like fibrils , 2010, Proceedings of the National Academy of Sciences.

[14]  Pawel Sikorski,et al.  The common architecture of cross-beta amyloid. , 2010, Journal of molecular biology.

[15]  Vincent B. Chen,et al.  Correspondence e-mail: , 2000 .

[16]  N. Grigorieff,et al.  Comparison of Alzheimer Aβ(1–40) and Aβ(1–42) amyloid fibrils reveals similar protofilament structures , 2009, Proceedings of the National Academy of Sciences.

[17]  S. Radford,et al.  Globular Tetramers of β2-Microglobulin Assemble into Elaborate Amyloid Fibrils , 2009, Journal of molecular biology.

[18]  S. Ludtke,et al.  Interprotofilament interactions between Alzheimer's Aβ1–42 peptides in amyloid fibrils revealed by cryoEM , 2009, Proceedings of the National Academy of Sciences.

[19]  G. Bitan,et al.  C-terminal peptides coassemble into Aβ42 oligomers and protect neurons against Aβ42-induced neurotoxicity , 2008, Proceedings of the National Academy of Sciences.

[20]  Jeffrey Skolnick,et al.  Fast procedure for reconstruction of full‐atom protein models from reduced representations , 2008, J. Comput. Chem..

[21]  N. Grigorieff,et al.  Paired β-sheet structure of an Aβ(1-40) amyloid fibril revealed by electron microscopy , 2008, Proceedings of the National Academy of Sciences.

[22]  C. Masters,et al.  Amyloid-beta-anti-amyloid-beta complex structure reveals an extended conformation in the immunodominant B-cell epitope. , 2008, Journal of molecular biology.

[23]  Michael Levitt,et al.  Combining efficient conformational sampling with a deformable elastic network model facilitates structure refinement at low resolution. , 2007, Structure.

[24]  N. Grigorieff,et al.  High-resolution electron microscopy of helical specimens: a fresh look at tobacco mosaic virus. , 2007, Journal of molecular biology.

[25]  D. Selkoe,et al.  Aβ Oligomers – a decade of discovery , 2007, Journal of neurochemistry.

[26]  Heather T. McFarlane,et al.  Atomic structures of amyloid cross-β spines reveal varied steric zippers , 2007, Nature.

[27]  D. Selkoe,et al.  Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide , 2007, Nature Reviews Molecular Cell Biology.

[28]  R. Glockshuber,et al.  Amyloid-beta aggregation. , 2007, Neuro-degenerative diseases.

[29]  David Eisenberg,et al.  Atomic structures of amyloid cross-beta spines reveal varied steric zippers. , 2007, Nature.

[30]  R. Riek,et al.  3D structure of Alzheimer's amyloid-β(1–42) fibrils , 2005 .

[31]  R. Riek,et al.  3D structure of Alzheimer's amyloid-beta(1-42) fibrils. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[32]  Conrad C. Huang,et al.  UCSF Chimera—A visualization system for exploratory research and analysis , 2004, J. Comput. Chem..

[33]  M. Nagao,et al.  Neurotoxicity and physicochemical properties of Abeta mutant peptides from cerebral amyloid angiopathy: implication for the pathogenesis of cerebral amyloid angiopathy and Alzheimer's disease. , 2003, The Journal of biological chemistry.

[34]  R. Henderson,et al.  Optimal determination of particle orientation, absolute hand, and contrast loss in single-particle electron cryomicroscopy. , 2003, Journal of molecular biology.

[35]  Wei Zhang,et al.  A point‐charge force field for molecular mechanics simulations of proteins based on condensed‐phase quantum mechanical calculations , 2003, J. Comput. Chem..

[36]  N. Grigorieff,et al.  Accurate determination of local defocus and specimen tilt in electron microscopy. , 2003, Journal of structural biology.

[37]  Ralf Langen,et al.  Structural and Dynamic Features of Alzheimer's Aβ Peptide in Amyloid Fibrils Studied by Site-directed Spin Labeling* , 2002, The Journal of Biological Chemistry.

[38]  M. Kirkitadze,et al.  Identification and characterization of key kinetic intermediates in amyloid beta-protein fibrillogenesis. , 2001, Journal of molecular biology.

[39]  R. Wetzel,et al.  Structural features of the Abeta amyloid fibril elucidated by limited proteolysis. , 2001, Biochemistry.

[40]  S. Younkin,et al.  The 'Arctic' APP mutation (E693G) causes Alzheimer's disease by enhanced Aβ protofibril formation , 2001, Nature Neuroscience.

[41]  W Chiu,et al.  EMAN: semiautomated software for high-resolution single-particle reconstructions. , 1999, Journal of structural biology.

[42]  Elena Orlova,et al.  Cryo‐electron microscopy structure of an SH3 amyloid fibril and model of the molecular packing , 1999, The EMBO journal.

[43]  J. Richardson,et al.  Asparagine and glutamine: using hydrogen atom contacts in the choice of side-chain amide orientation. , 1999, Journal of molecular biology.

[44]  C. Glabe,et al.  Soluble Amyloid Aβ-(1–40) Exists as a Stable Dimer at Low Concentrations* , 1997, The Journal of Biological Chemistry.

[45]  P. Lansbury,et al.  Models of amyloid seeding in Alzheimer's disease and scrapie: mechanistic truths and physiological consequences of the time-dependent solubility of amyloid proteins. , 1997, Annual review of biochemistry.

[46]  A Leith,et al.  SPIDER and WEB: processing and visualization of images in 3D electron microscopy and related fields. , 1996, Journal of structural biology.

[47]  D. van der Spoel,et al.  GROMACS: A message-passing parallel molecular dynamics implementation , 1995 .

[48]  H. Bekker,et al.  Force and virial of torsional‐angle‐dependent potentials , 1995, J. Comput. Chem..